Procept Biorobotics Corp (PRCT) stock news · rev $308.1M
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
This PRCT news page leads with what Procept Biorobotics Corp filed — not a scraped headline mill.
No cached 8-K sentence for PRCT yet. We will not pad this page with generic market recap.
Latest reported PRCT revenue for 2025-12-31 was $308.1M. Net income was -$95.6M. Revenue was up 37.2% from 2024-12-31 to 2025-12-31. PRCT currently screens at market cap $1.52B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PRCT stock page; for the tape open the quote page.
PRCT stock news FAQ
What are PRCT's latest revenue and net income?
Latest cached Procept Biorobotics Corp (PRCT) revenue for Dec 31, 2025 was $308.1M. Net income was -$95.6M. Statements: https://lician.com/financials/prct
How did PRCT revenue change from the prior cached period?
Cached Procept Biorobotics Corp (PRCT) revenue was up 37.2% from $224.5M (Dec 31, 2024) to $308.1M (Dec 31, 2025). Statements: https://lician.com/financials/prct
What is PRCT's market cap?
Procept Biorobotics Corp (PRCT) market cap is $1.52B on the latest cached fundamentals snapshot.
What kind of company is PRCT?
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Where is PRCT stock news listed?
Cached stock news for Procept Biorobotics Corp (PRCT) is listed at https://lician.com/news/prct. Filings: https://lician.com/sec/prct
Not investment advice.